BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6480761)

  • 1. Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin.
    Mallet AI; Cunningham FM; Daniel R
    J Chromatogr; 1984 Jul; 309(1):160-4. PubMed ID: 6480761
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography.
    Wardlow ML
    J Chromatogr; 1985 Aug; 342(2):380-4. PubMed ID: 4055961
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet activating factor (PAF) and lyso-PAF in psoriasis.
    Judge MR; Barr RM; Mallet AI; Courtney F; Kobza Black A; Greaves MW
    Arch Dermatol Res; 1994; 286(7):376-9. PubMed ID: 7818279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of lyso-platelet-activating factor by high-performance liquid chromatography after derivatisation with fluorescent fatty acids.
    Salari H; Eigendorf GK
    J Chromatogr; 1990 May; 527(2):303-14. PubMed ID: 2387879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-enzymatic platelet-activating factor formation by acetylated proteins.
    Thanou PG; Tsoukatos DC
    FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
    Balazy M; Braquet P; Bazan NG
    Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo metabolism of platelet-activating-factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by the protozoan Tetrahymena pyriformis.
    Lekka ME; Tsoukatos D; Kapoulas VM
    Biochim Biophys Acta; 1990 Feb; 1042(2):217-20. PubMed ID: 2105748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin.
    Calignano A; Cirino G; Meli R; Persico P
    J Pharmacol Methods; 1988 Mar; 19(1):89-91. PubMed ID: 3367652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
    Barr RM; Lawlor F; Judge MR; Courtney P; Barlow R; Kobza Black A; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1993 Jun; 35(6):637-41. PubMed ID: 8329291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor.
    Owen JS; Thomas MJ; Wykle RL
    Methods Enzymol; 2007; 434():105-16. PubMed ID: 17954244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural identification of platelet activating factor in psoriatic scale.
    Mallet AI; Cunningham FM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):192-8. PubMed ID: 3970690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species.
    Robinson M; Snyder F
    Biochim Biophys Acta; 1985 Oct; 837(1):52-6. PubMed ID: 4052436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes.
    Pinckard RN; Jackson EM; Hoppens C; Weintraub ST; Ludwig JC; McManus LM; Mott GE
    Biochem Biophys Res Commun; 1984 Jul; 122(1):325-32. PubMed ID: 6743335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermospray liquid chromatography/mass spectrometry of ether phosphocholines.
    Mallet AI; Rollins K
    Biomed Environ Mass Spectrom; 1986 Oct; 13(10):541-3. PubMed ID: 2947648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of embryo-derived platelet-activating factor in mice.
    Kodama H; Muto H; Maki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jul; 41(7):899-906. PubMed ID: 2794622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved high-performance liquid chromatographic method for isolation of platelet-activating factor from other phospholipids.
    Blank ML; Snyder F
    J Chromatogr; 1983 Apr; 273(2):415-20. PubMed ID: 6863454
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet-activating factor in human normal tears.
    Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
    Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
    Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
    Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection.
    Andrikopoulos NK; Demopoulos CA; Siafaka-Kapadai A
    J Chromatogr; 1986 Aug; 363(2):412-7. PubMed ID: 3771693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.